Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Negus

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1992
Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant ratsM J Picker, R M Craft, S S Negus, et al.
British Journal of Pharmacology|December 19, 2014
Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analoguesF Sakloth, R Kolanos, P D Mosier, et al.
Psychopharmacology|February 25, 2022
Opioid-like adverse effects of tianeptine in male rats and miceT R Baird, H I Akbarali, W L Dewey, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2001
Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine abuse: synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinanJ L Neumeyer, X H Gu, L A van Vliet, et al.
British Journal of Pharmacology|December 3, 2014
Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analoguesJ S Bonano, M L Banks, R Kolanos, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2016
Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro AssaysT W Grim, A J Morales, M M Gonek, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1992
Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant ratsM J Picker, R M Craft, S S Negus, et al.
British Journal of Pharmacology|December 19, 2014
Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analoguesF Sakloth, R Kolanos, P D Mosier, et al.
Psychopharmacology|February 25, 2022
Opioid-like adverse effects of tianeptine in male rats and miceT R Baird, H I Akbarali, W L Dewey, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2001
Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine abuse: synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinanJ L Neumeyer, X H Gu, L A van Vliet, et al.
British Journal of Pharmacology|December 3, 2014
Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analoguesJ S Bonano, M L Banks, R Kolanos, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2016
Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro AssaysT W Grim, A J Morales, M M Gonek, et al.
Pageof 12